Expanded Global Portfolio Enhances Competitive Position and Supports Long-Term Growth Strategy LOS GATOS, CA / ACCESS Newswire / February 18, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced a strategic expansion of its U.S. intellectual property portfolio following receipt of Notices of Allowance from the United States Patent and Trademark Office (USPTO) for multiple patent applications expected to issue in 2026. These newly allowed claims will further strengthen the Company's growing patent portfolio and build upon the (10) ten patents issued in 2025, including (5) five issued by the USPTO and (5) five issued internationally.

Tenon Medical (NASDAQ: TNON - Get Free Report) and Positron (OTCMKTS:POSC - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings. Institutional and Insider Ownership 22.7% of Tenon Medical

Fourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over year Full Year 2025 Revenue of $3.91 to $3.94 Million, representing growth of ~20% year over year LOS GATOS, CA / ACCESS Newswire / February 5, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced plans to release financial results for the fourth quarter and full year 2025 ended December 31, 2025 after market close on Thursday, March 19, 2026. The Company will also hold a conference call on the same day at 4:30 p.m.

Tenon Medical (NASDAQ: TNON - Get Free Report) and Waters (NYSE: WAT - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Institutional and Insider Ownership 22.7% of Tenon Medical shares

Beta Bionics, Inc. (NASDAQ: BBNX - Get Free Report)'s stock price dropped 9.2% during mid-day trading on Monday after Wall Street Zen downgraded the stock from a hold rating to a sell rating. The stock traded as low as $17.83 and last traded at $18.28. Approximately 378,461 shares traded hands during mid-day trading, a decline of

Tenon Medical, Inc. (NASDAQ: TNON - Get Free Report)'s share price dropped 1.7% on Monday. The company traded as low as $0.94 and last traded at $0.9531. Approximately 95,534 shares changed hands during mid-day trading, an increase of 39% from the average daily volume of 68,767 shares. The stock had previously closed at $0.97. Analyst

Beta Bionics (NASDAQ: BBNX - Get Free Report) and Tenon Medical (NASDAQ: TNON - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, earnings, risk and dividends. Insider and Institutional Ownership 22.7% of Tenon

~ Procedures Completed in Various Spine Centers of Excellence Throughout the Country Including Florida, Arizona, Ohio, and Texas ~ ~ SImmetry+ combines 3D-printed titanium implants, a robust joint decorticator, and a streamlined bone graft delivery system to offer treatment solutions aligned with established fusion principles ~ ~ Immediate revenue impact opportunity while significantly advancing Tenon's competitive position in redefining SI joint fusion with a multi-approach portfolio in rapidly expanding sacro-pelvic market ~ LOS GATOS, CA / ACCESS Newswire / December 4, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced the completion of the first clinical procedures utilizing the Company's new SImmetry+ SI Joint Fusion System. Ali Araghi, DO, Orthopedic Spine Surgeon in Phoenix, Arizona, Brian Fiani, DO Board Certified Neurosurgeon in Tampa, FL.

IQVIA (NYSE: IQV - Get Free Report) and Tenon Medical (NASDAQ: TNON - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, valuation and institutional ownership. Analyst Recommendations This is a summary of recent recommendations

LOS GATOS, CA / ACCESS Newswire / November 14, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced the successful closing of its previously announced at-the-market private investment in public equity (the "PIPE") financing. As part of the closing of the PIPE, Tenon Medical has issued an aggregate of 2,217,904 shares of common stock (the "Issued Shares") along with warrants (the "PIPE Warrants") to purchase an equal number of shares.